🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 7 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/04/2025 | 106,06 | 107,27 | 104,00 | 106,80 | +0,20% | 3,08% | 59.900 |
| 14/04/2025 | 104,07 | 107,62 | 100,30 | 106,59 | +2,22% | 7,03% | 114.300 |
| 11/04/2025 | 101,60 | 105,11 | 100,74 | 104,27 | +2,94% | 4,30% | 71.300 |
| 10/04/2025 | 104,60 | 104,86 | 97,48 | 101,29 | -2,47% | 7,06% | 115.900 |
| 09/04/2025 | 95,24 | 106,35 | 93,58 | 103,85 | +7,43% | 13,41% | 161.200 |
| 08/04/2025 | 102,00 | 102,70 | 94,77 | 96,67 | -2,76% | 7,77% | 160.000 |
| 07/04/2025 | 94,56 | 102,55 | 94,00 | 99,41 | -0,16% | 9,04% | 201.800 |
| 04/04/2025 | 99,17 | 101,15 | 96,76 | 99,57 | -3,43% | 4,43% | 165.800 |
| 03/04/2025 | 103,16 | 106,63 | 101,73 | 103,11 | -5,17% | 4,75% | 115.300 |
| 02/04/2025 | 102,60 | 108,77 | 102,60 | 108,73 | +3,73% | 6,01% | 130.000 |
| 01/04/2025 | 104,95 | 107,49 | 102,50 | 104,82 | -0,30% | 4,75% | 97.800 |
| 31/03/2025 | 105,55 | 106,37 | 103,06 | 105,14 | -2,30% | 3,14% | 153.400 |
| 28/03/2025 | 108,91 | 109,82 | 106,43 | 107,62 | -1,90% | 3,11% | 68.300 |
| 27/03/2025 | 108,45 | 112,49 | 107,61 | 109,70 | +1,49% | 4,50% | 131.200 |
| 26/03/2025 | 109,54 | 111,52 | 107,61 | 108,09 | -1,46% | 3,57% | 86.300 |
| 25/03/2025 | 111,70 | 112,53 | 109,36 | 109,69 | -1,77% | 2,84% | 164.800 |
| 24/03/2025 | 110,36 | 112,61 | 108,88 | 111,67 | +3,25% | 3,38% | 96.800 |
| 21/03/2025 | 108,07 | 111,86 | 106,79 | 108,15 | -1,15% | 4,69% | 280.800 |
| 20/03/2025 | 106,87 | 110,73 | 106,87 | 109,41 | +1,28% | 3,61% | 94.800 |
| 19/03/2025 | 106,17 | 109,08 | 105,24 | 108,03 | +1,70% | 3,62% | 125.100 |
| 18/03/2025 | 108,04 | 108,13 | 103,53 | 106,22 | -3,39% | 4,26% | 128.600 |
| 17/03/2025 | 105,63 | 112,98 | 104,84 | 109,95 | +3,54% | 7,71% | 167.000 |
| 14/03/2025 | 107,18 | 109,25 | 105,23 | 106,19 | +0,54% | 3,75% | 147.300 |
| 13/03/2025 | 108,15 | 109,27 | 103,43 | 105,62 | -2,29% | 5,40% | 120.900 |
| 12/03/2025 | 106,16 | 111,22 | 106,00 | 108,09 | +2,17% | 4,92% | 191.500 |
| 11/03/2025 | 109,00 | 109,47 | 105,02 | 105,79 | -3,21% | 4,08% | 171.300 |
| 10/03/2025 | 112,81 | 112,81 | 105,93 | 109,30 | -4,82% | 6,10% | 130.600 |
| 07/03/2025 | 114,80 | 117,10 | 112,13 | 114,83 | -1,01% | 4,33% | 119.500 |
| 06/03/2025 | 113,14 | 116,65 | 113,14 | 116,00 | +0,51% | 3,10% | 87.400 |
| 05/03/2025 | 115,40 | 117,58 | 112,72 | 115,41 | +0,13% | 4,21% | 99.800 |